SZLSF Stock Price, Chart, Stats & News

StageZero Life Sciences Ltd.
Save
StageZero Life Sciences Ltd. (SZLSF) does not currently pay a dividend.
123,533
Market cap
–
Current P/E
3.48x
Forward P/E
SZLSF chart
About
Health care
Sector
Medical - Diagnostics & Research
Industry
StageZero Life Sciences Ltd. is a vertically integrated healthcare enterprise focused on the development and commercialization of proprietary molecular diagnostic tests. These tests are primarily designed for the early detection of diseases and to facilitate personalized health management, with a particular emphasis on oncology-related conditions within the United States and Canada. At the core of their offerings is the proprietary Sentinel Principle platform technology, which specializes in identifying novel biomarkers from whole blood samples.
Similar securities
Based on sector and market capitalization
Report issue





